A biotech aggregator supports the accelerated development of life science technologies by partnering with entrepreneurs, offering leadership and operational expertise to enhance early drug and technology development for serious diseases. This model helps scientific founders maintain control and equity while improving their chances of attracting investment and achieving successful outcomes.